Track Coloplast A/S — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Coloplast A/S CLPBY · Stock Open Coloplast A/S in new tab

7.24 USD
Add to portfolio
P/E
34.90
EPS
0.19
Yield
5.24%
Safety Score
21
P/B
7.59
ROE
18.53
Beta
0.55
Target Price
8.27 USD
Coloplast A/S logo

Coloplast A/S

🧾 Earnings Recap – Q3 2026

Shares rose 6.1% as Coloplast reassured investors with sustained leadership positions, a strong product portfolio, and clear strategic priorities to drive growth, particularly emphasizing growth potential in the U.S. market.

  • Chronic Care remains the core segment, representing over 75% of sales, with continued leadership and an annuity-based business model reinforcing revenue stability.
  • U.S. market highlighted as a significant growth opportunity, currently under-penetrated with market shares of 15-20% in Ostomy Care and about 30% in Continence Care.
  • Biologics segment in Wound & Tissue Repair faces challenges due to a recent U.S. market reset but focusing on inpatient care and clinical differentiation to restore profitable growth.
  • New CEO Gavin Wood is prioritizing disciplined capital allocation, investment governance, and innovation pipeline to accelerate growth and extend competitive moats.
  • Leadership changes include appointing a new Chief People Officer and executive realignment in Wound & Tissue Repair to strengthen organizational focus and execution.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 3, 2026
P/E34.90
EPS0.19
Book Value0.92
Price to Book7.59
Debt/Equity178.07
Growth
Revenue Growth0.06%
Earnings Growth0.82%
Estimates
Forward P/E17.01
Forward EPS0.41
Target Mean Price8.27
Dividend
Dividend Yield5.24%
Annual dividends2.30 USD
Ex-Div. DateMay 22, 2026
Payout187.59%
5y avg Yield2.25%

DCF Valuation

Tweak assumptions to recompute fair value for Coloplast A/S (CLPBY)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Coloplast A/S Logo Coloplast A/S Analysis (CLPBY)

Denmark Health Care Official Website Stock

Is Coloplast A/S a good investment? Coloplast A/S (CLPBY) is currently trading at 7.24 USD. Market analysts have a consensus price target of 8.27 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 34.90. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Coloplast A/S is expected to release its next earnings report on Nov. 3, 2026. The market consensus estimate for Forward EPS is 0.41.

For income investors, Coloplast A/S pays a dividend yield of 5.24%. With a payout ratio of 188%, the dividend appears to be under pressure.

Investor FAQ

Does Coloplast A/S pay a dividend?

Yes, it pays an annual dividend of 2.30 USD (5.24% yield).

What asset class is Coloplast A/S?

Coloplast A/S is classified as a Stock. You can compare it against 4 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 3, 2026. The company currently has a trailing EPS of 0.19.

Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Exchange Ticker
PNK (United States) CLPBY
VIE (Austria) COLO.VI
MEX (Mexico) 0QBON.MX
FRA (Germany) CBHD.F
Trades
Dividend Yield
5.24%
5y avg 2.25%
Annual Dividends
2.30USD
Next Ex. Div Date
May 22, 2026
Payout Ratio
187.59%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
0.08 USD
June 1, 2027 (estimated) 0.0790
▸2026
0.37 USD
Dec. 24, 2026 (estimated) 0.2913
June 1, 2026 0.0790
▸2025
0.36 USD
Dec. 19, 2025 0.2821
May 22, 2025 0.0750
▸2024
0.31 USD
Dec. 20, 2024 0.2390
May 28, 2024 0.0720
▸2023
0.31 USD
Dec. 22, 2023 0.2330
May 30, 2023 0.0740
▸2022
0.28 USD
Dec. 16, 2022 0.2100
May 23, 2022 0.0710
▸2021
0.29 USD
Dec. 17, 2021 0.2130
May 24, 2021 0.0810
▸2020
0.28 USD
Dec. 18, 2020 0.2110
May 26, 2020 0.0730
▸2019
0.25 USD
Dec. 24, 2019 0.1780
May 22, 2019 0.0750
▸2018
0.25 USD
Dec. 24, 2018 0.1677
May 23, 2018 0.0795
▸2017
0.23 USD
Dec. 27, 2017 0.1645
May 24, 2017 0.0657
▸2016
0.20 USD
Dec. 22, 2016 0.1282
May 26, 2016 0.0690
▸2015
0.18 USD
Dec. 28, 2015 0.1174
May 26, 2015 0.0671
▸2014
0.20 USD
Dec. 23, 2014 0.1246
May 29, 2014 0.0737
▸2013
0.13 USD
Dec. 24, 2013 0.1291
Upcoming Dividends
Name Payment Date Status Amount
Coloplast A/S Jun 01, 2026 0.079 USD
Coloplast A/S Dec 19, 2025 0.28212 USD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion